Is Meloxicam Approved for Rheumatoid Arthritis Flares?
Meloxicam (brand name Mobic) is an NSAID approved by the FDA for treating symptoms of rheumatoid arthritis (RA), including pain, inflammation, and stiffness during flares. It reduces prostaglandin production to ease joint swelling and discomfort. Guidelines from the American College of Rheumatology list it as an option for short-term RA flare relief, often as first-line therapy alongside DMARDs like methotrexate.
How Effective Is It for RA Flares?
Clinical trials show meloxicam 7.5-15 mg daily reduces RA flare pain by 40-50% within 1-2 weeks, comparable to diclofenac or naproxen. It works faster for acute flares than biologics but doesn't alter disease progression—pair it with RA disease-modifying drugs for long-term control.
What Dosage and Timing Work Best for Flares?
Standard dose for RA is 7.5 mg once daily, up to 15 mg if needed. Take with food to minimize stomach upset. For flares, doctors often prescribe it short-term (days to weeks) until flare subsides. Don't exceed 15 mg/day or use longer than recommended without monitoring.
What Are the Main Risks and Side Effects?
Common issues include stomach pain, nausea, heartburn (10-20% of users), and elevated blood pressure. Serious risks: GI bleeding/ulcers (higher with age >65, alcohol use, or steroids), heart attack/stroke (black box warning), kidney damage. Avoid if you have heart disease, ulcers, or are pregnant (especially third trimester). Long-term use raises these risks—monitor with blood tests.
Who Should Avoid It or Use Caution?
Skip meloxicam if you have active ulcers, severe kidney/liver issues, or recent heart bypass. Use lowest dose shortest time in elderly patients. Drug interactions: Increases bleeding risk with blood thinners (warfarin), weakens effects of blood pressure meds, or diuretics. Tell your doctor about all meds.
How Does It Compare to Other RA Flare Options?
| Option | Speed for Flares | Key Pros | Key Cons |
|--------|------------------|----------|----------|
| Meloxicam (NSAID) | 1-3 days | Cheap (generic ~$10/month), once-daily | GI/heart risks |
| Ibuprofen/Naproxen (other NSAIDs) | Similar | OTC availability | More frequent dosing |
| Prednisone (steroid) | Hours-days | Potent for severe flares | Weight gain, osteoporosis with prolonged use |
| TNF inhibitors (e.g., Humira) | Weeks | Disease-modifying | Expensive, injection required |
Switch if meloxicam fails; biologics target flares better long-term.
When to See a Doctor Before Starting?
Always consult your rheumatologist first—self-medicating ignores RA-specific factors like your disease stage or comorbidities. They may test for H. pylori or add PPI (e.g., omeprazole) for stomach protection. Not for everyone; alternatives exist if contraindicated.
Sources:
[1] FDA Label for Mobic](https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020938s050lbl.pdf)
[2] American College of Rheumatology RA Guidelines (2021)](https://rheumatology.org/rheumatoid-arthritis-guideline)
[3] DrugPatentWatch.com (meloxicam patents expired 2010-2014; generics available)](https://www.drugpatentwatch.com/p/tradename/MOBIC)